| Literature DB >> 28623314 |
Bo Zhang1, Yangzom Chamba2, Peng Shang1,2, Zhixiu Wang1, Jun Ma1, Liyuang Wang1, Hao Zhang3.
Abstract
Tibetan pigs that inhabit the Tibetan Plateau exhibit striking phenotypic and physiological differences from lowland pigs, and have adapted well to extreme conditions. However, the mechanisms involved in regulating gene expression at high altitude in these animals are not fully understood. In this study, we obtained transcriptomic and proteomic data from the heart tissues of Tibetan and Yorkshire pigs raised in the highlands (TH and YH) and lowlands (TL and YL) via RNA-seq and iTRAQ (isobaric tags for relative and absolute quantitation) analyses, respectively. Comparative analyses of TH vs. YH, TH vs.TL, TL vs. YL, and YH vs. YL yielded 299, 169, 242, and 368 differentially expressed genes (DEGs), and 473, 297, 394, and 297 differentially expressed proteins (DEPs), respectively. By functional annotation of these DEGs and DEPs, genes that were enriched in the HIF-1 signaling pathway (NPPA, ERK2, ENO3, and EGLN3), VEGF signaling pathway (ERK2, A2M, FGF1, CTGF, and DPP4), and hypoxia-related processes (CRYAB, EGLN3, TGFB2, DPP4, and ACE) were identified as important candidate genes for high-altitude adaptation in the Tibetan pig. This study enhances our understanding of the molecular mechanisms involved in hypoxic adaptation in pigs, and furthers our understanding of human hypoxic diseases.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28623314 PMCID: PMC5473931 DOI: 10.1038/s41598-017-03976-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Potential key differentially expressed genes (DEGs) and their functions related to hypoxic adaption in the Tibetan pig.
| Gene | TH/YH | TL/YL | TH/TL | YH/YL | Functional analysis |
|---|---|---|---|---|---|
|
| 0.44 | 0.25 | 1.43 | 0.81 | Complement and coagulation cascades, blood microparticle, VEGF signaling pathway |
|
| 0.63 | 2.94 | 0.57 | 2.68 | Renin-angiotensin system, vasculature development, muscle contraction, blood vessel development, regulation of blood pressure |
|
| 3.44 | 1.18 | 4.19 | 1.44 | angiogenesis, vasculature development, |
|
| 6.18 | 17.30 | 0.27 | 0.77 | gluconeogenesis, DNA binding |
|
| 2.82 | 0.82 | 5.80 | 1.68 | ECM-receptor interaction, Hematopoietic cell lineage |
|
| 0.48 | 1.11 | 0.75 | 1.71 | immune response, response to insulin stimulus |
|
| 1.58 | 4.95 | 0.50 | 1.55 | response to radiation, blood vessel development |
|
| 2.20 | 0.68 | 4.68 | 1.45 | mitochondrion, response to hypoxia, response to reactive oxygen species |
|
| 5.72 | 3.31 | 1.58 | 0.91 | lung development, blood vessel development, vasculature development, angiogenesis, blood vessel morphogenesis, reactive oxygen species metabolic process, cardiovascular development, VEGF signaling pathway |
|
| 3.92 | 2.96 | 1.50 | 1.13 | MAPK signaling pathway |
|
| 0.47 | 0.72 | 0.78 | 1.21 | Pathways in cancer, renal cell carcinoma, oxidation-reduction process, response to hypoxia, HIF-1 signaling pathway |
|
| 4.32 | 1.55 | 0.33 | 1.59 | MAPK signaling pathway, Pathways in cancer, blood vessel morphogenesis, blood vessel development, respiratory system development, cardiovascular development, VEGF signaling pathway |
|
| 0.22 | 0.31 | 0.55 | 0.75 | response to hypoxia, response to oxygen levels, VEGF signaling pathway |
|
| 2.27 | 1.94 | 2.00 | 1.71 | cardiac myofibril assembly, hemoglobin complex, oxygen transport |
|
| 2.26 | 2.73 | 1.60 | 1.93 | cardiac myofibril assembly, hemoglobin complex, oxygen transport |
|
| 37.60 | 2.31 | 27.27 | 1.68 | regulation of blood vessel size, cardiac muscle hypertrophy in response to stress, HIF-1 signaling pathway, regulation of blood vessel size, circulatory system process, regulation of blood pressure, hypertrophy in response to stress |
|
| 41.96 | 0.17 | 138.23 | 0.57 | regulation of blood vessel size, regulation of blood vessel size, circulatory system process |
|
| 0.42 | 1.02 | 0.40 | 0.97 | Mitochondrion, reductase (NADPH) activity, NADPH binding |
|
| 9.24 | 1.74 | 2.03 | 0.38 | heart development, vasculature development, cardiac muscle tissue development, response to oxygen levels, response to hypoxia, angiogenesis, regulation of heart contraction, immune system development, pathways in cancer, TGF-beta signaling pathway |
|
| 2.03 | 2.58 | 4.33 | 5.49 | heart development, cardiovascular development |
|
| 14.93 | 24.97 | 0.54 | 0.91 | DNA binding, cellular response to reactive oxygen species, pertussis, pathways in cancer |
TH, Tibetan highland pig; TL, Tibetan lowland pig; YH, Yorkshire highland pig; YL, Yorkshire lowland pig.
Figure 1Venn diagram of differentially expressed genes (DEGs) among the four comparison groups. TH, Tibetan highland pig; TL, Tibetan lowland pig; YH, Yorkshire highland pig; YL, Yorkshire lowland pig.
Figure 2Differentially expressed protein (DEP) pathway analysis. TH, Tibetan highland pig; TL, Tibetan lowland pig; YH, Yorkshire highland pig; YL, Yorkshire lowland pig.
Summary of hypoxia-regulated differentially expressed proteins (DEPs).
| Protein | TH/YH | TL/YL | TH/TL | YH/YL | Functional analysis |
|---|---|---|---|---|---|
| MYL7 | 2.05 | 0.79 | 1.60 | 0.62 | muscle contraction, actin cytoskeleton, actin binding, ATPase activity, contractile fiber part |
| PTPMT1 | 1.46 | 0.67 | 1.80 | 0.83 | mitochondrion, inflammatory response, acute inflammatory response |
| PDLIM3 | 1.60 | 1.21 | 1.34 | 1.02 | heart development, actin cytoskeleton, contractile fiber, cardiovascular development |
| A2M | 1.42 | 0.72 | 1.62 | 0.83 | Complement and coagulation cascades, blood microparticle, inflammatory response, regulation of immune effector process, VEGF signaling pathway |
| C6 | 1.29 | 0.78 | 1.28 | 0.77 | inflammatory response, positive regulation of immune system process, acute inflammatory response, positive regulation of immune response, response mediated by circulating, defense response |
| CRYAB | 1.46 | 0.86 | 1.41 | 0.82 | response to hypoxia, mitochondrion, response to reactive oxygen species, oxygen and reactive oxygen species metabolic process, muscle contraction, oxygen species metabolic process |
| PDK4 | 1.10 | 1.02 | 1.45 | 1.34 | mitochondrion, ATP binding, mitochondrion, reactive oxygen species metabolic process, glucose metabolic process |
| ERK2 | 1.20 | 0.98 | 1.15 | 0.94 | HIF-1 signaling pathway, mTOR signaling pathway, TGF-beta signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, cardiac muscle contraction |
| ACE | 1.25 | 0.77 | 1.30 | 0.80 | Vasculature development, response to oxygen levels, response to hypoxia, immune system development, regulation of blood pressure, heart contraction, Renin-angiotensin system, blood circulation |
| NAPG | 1.24 | 0.77 | 1.21 | 0.75 | mitochondrion, inflammatory response, actin filament binding, |
| CPS1 | 1.22 | 0.44 | 1.49 | 0.54 | mitochondrion, glucose metabolic process, oxidation of organic compounds |
| HSPE1 | 0.98 | 1.50 | 0.80 | 1.23 | inflammatory response, mitochondrion |
| DECR1 | 0.95 | 1.59 | 0.81 | 1.35 | mitochondrion, 2, 4-dienoyl-CoA reductase (NADPH) activity, NADPH binding, oxidation reduction, iron ion homeostasis, muscle contraction |
| AHSG | 0.72 | 1.20 | 0.78 | 1.30 | inflammatory response, defense response, |
| ENO3 | 0.76 | 1.20 | 0.65 | 1.03 | HIF-1 signaling pathway, glycolysis/gluconeogenesis, glucose metabolic process |
| MRPS26 | 0.63 | 1.40 | 0.68 | 1.52 | mitochondrion, ribosome |
| DCN | 0.50 | 0.80 | 0.80 | 1.29 | TGF-beta signaling pathway |
| COL3A1 | 0.41 | 0.70 | 0.83 | 1.41 | response to radiation, blood vessel development, Platelet activation |
| COL1A2 | 0.40 | 0.80 | 0.83 | 1.65 | blood circulation, regulation of blood pressure, small GTPase mediated signal transduction |
| KRT8 | 0.32 | 0.67 | 0.75 | 1.56 | contractile fiber part |
TH, Tibetan highland pig; TL, Tibetan lowland pig; YH, Yorkshire highland pig; YL, Yorkshire lowland pig.